Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Testing effectiveness (Phase 2)Study completedNCT01443065What this trial is testingMEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaWho this might be right forMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach UNICANCER 162
Not applicableStudy completedNCT06897306What this trial is testingGastric-type Endocervical Adenocarcinoma: a Population-based Cohort StudyWho this might be right forUterine Cervical NeoplasmsSurgeryTherapy+1 more Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 317
Testing effectiveness (Phase 2)Study completedNCT00121628What this trial is testingA Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerWho this might be right forThyroid Cancer Amgen 184
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00020787What this trial is testingVaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Jonsson Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT01107639What this trial is testingRadiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer Swiss Cancer Institute 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT01709292What this trial is testingVemurafenib Neoadjuvant Trial in Locally Advanced Thyroid CancerWho this might be right forThyroid Cancer M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00938470What this trial is testingDocetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 73
Testing effectiveness (Phase 2)Study completedNCT00358956What this trial is testingAssess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerWho this might be right forThyroid Cancer Genzyme, a Sanofi Company 19
Testing effectiveness (Phase 2)Ended earlyNCT00101075What this trial is testingTitle XELOX FOR SALIVARY GLAND CANCERSWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 9
Large-scale testing (Phase 3)Study completedNCT01365156What this trial is testingExtraperitoneal Para-aortic Lymph Node Dissection (EPLND) for CervixWho this might be right forCervical Squamous Cell CarcinomaAdenosquamous CarcinomaAdenocarcinoma+2 more M.D. Anderson Cancer Center 28
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Early research (Phase 1)Ended earlyNCT00368329What this trial is testingPhase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal CancerWho this might be right forEsophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinoma+1 more Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT00445861What this trial is testingCetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryWho this might be right forEsophageal Cancer Swiss Cancer Institute 27
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Not applicableLooking for participantsNCT06028724What this trial is testingA Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)Who this might be right forSolid TumorAdvanced Solid TumorLocally Advanced Solid Tumor+11 more Centro di Riferimento Oncologico - Aviano 782
Large-scale testing (Phase 3)Study completedNCT00410761What this trial is testingAn Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerWho this might be right forThyroid Cancer Genzyme, a Sanofi Company 331
Early research (Phase 1)Active Not RecruitingNCT05867303What this trial is testingA RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forMelanomaUrothelial CarcinomaRenal Cell Carcinoma+3 more RemeGen Co., Ltd. 48
Not applicableStudy completedNCT00895349What this trial is testingImpact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)Who this might be right forCervical CancerSquamous Cell CarcinomaAdenosquamous Carcinoma+1 more Ontario Clinical Oncology Group (OCOG) 171